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Regulatory T cells (T reg cells) that express the 
Foxp3 transcription factor and suppress immu-
nity are generated in the thymus and are called 
nT  reg  cells  (Marie  et  al.,  2005;  Sakaguchi, 
2005). CD4+Foxp3+ T reg cells are also induced 
(iT reg cells) in the periphery upon TCR stim-
ulation  in  the  presence  of TGF-  (Shevach   
et al., 2008) with either anti-CD3 (Chen et al., 
2003) or antigen-presenting DCs (Luo et al., 
2007;  Yamazaki et al., 2007). The vitamin A me-
tabolite all-trans retinoic acid (ATRA) enhances 
iT reg cell formation along with TGF- (Benson 
et al., 2007; Coombes et al., 2007; Mucida et al., 
2007; Sun et al., 2007; von Boehmer, 2007; 
Hill et al., 2008). Antigen-specific iT reg cells 
have the potential to suppress autoimmunity, 
allergy, and transplantation (Horwitz et al., 2004). 
However, a major gap, which limits their thera-
peutic use, is to sustain Foxp3 expression after 
adoptive transfer in vivo (Sakaguchi et al., 2008; 
Edinger, 2009).
In the case of nT reg cells, adoptively trans-
ferred polyclonal populations can ameliorate 
immune pathology (Roncarolo and Battaglia, 
2007) and recently were found to exhibit stability 
under physiological and inflammatory condi-
tions (Rubtsov et al., 2010). Nevertheless, there 
are several studies reporting that T reg cells 
lower their expression of the essential tran-
scription factor Foxp3 in the context of in-
flammation (Wan and Flavell, 2007; Tang et al., 
2008; Murai et al., 2009; Zhou et al., 2009). 
Less certain, however, is whether iT reg cells, 
especially antigen-specific iT reg cells induced 
in  vitro,  can  sustain  Foxp3  expression  and   
suppressive function upon reengagement with   
antigen in vivo (Sakaguchi et al., 2008; Edinger, 
2009).The instability of iT reg cells is attrib-
uted at least in part to a low demethylation 
status of specific conserved noncoding sequences 
(CNSs) in the Foxp3 gene, which are fully 
demethylated in nT reg cells (Floess et al., 2007; 
Kim and Leonard, 2007; Polansky et al., 2008; 
Zheng et al., 2010).
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Foxp3+ regulatory T cells (T reg cells) effectively suppress immunity, but it is not determined 
if antigen-induced T reg cells (iT reg cells) are able to persist under conditions of inflamma-
tion and to stably express the transcription factor Foxp3. We used spleen cells to stimulate 
the mixed leukocyte reaction (MLR) in the presence of transforming growth factor  (TGF-) 
and retinoic acid. We found that the CD11chigh dendritic cell fraction was the most potent 
at inducing high numbers of alloreactive Foxp3+ cells. The induced CD4+CD25+Foxp3+ cells 
appeared after extensive proliferation. When purified from the MLR, iT reg cells suppressed 
both primary and secondary MLR in vitro in an antigen-specific manner. After transfer into 
allogeneic mice, iT reg cells persisted for 6 mo and prevented graft versus host disease 
(GVHD) caused by co-transferred CD45RBhi T cells. Similar findings were made when iT reg 
cells were transferred after onset of GVHD. The CNS2 intronic sequence of the Foxp3 gene 
in the persisting iT reg cells was as demethylated as the corresponding sequence of naturally 
occurring T reg cells. These results indicate that induced Foxp3+ T reg cells, after proliferat-
ing and differentiating into antigen-specific suppressive T cells, can persist for long periods 
while suppressing a powerful inflammatory disease.
© 2011 Sela et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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20 ng/ml TGF- alone or with ATRA, a recently described 
co-factor  for  T  reg  cell  development  in  the  periphery   
(see Introduction). Without TGF-, DCs induced a vigorous 
MLR, but only 1% of proliferating CFSE-low cells was 
Foxp3+. Addition of TGF- or TGF- plus ATRA greatly 
increased the induction of CD4+CD25+Foxp3+ (RFP+) cells 
to 20 and 70%, respectively, of the viable cells (Fig. 1 A, 
left FACS). At an optimal dose of 20 ng/ml TGF-, increas-
ing doses of ATRA up to 10 nM increased the frequency 
and absolute number of induced CD4+CD25+Foxp3+ cells 
(Fig. 1 A, right), with no induction by ATRA alone (not 
depicted). Only the CD11c+ spleen cells induced T reg cells 
(Fig. 1 B). Splenocytes selected by anti-CD11c beads are 
not pure DCs, so we further separated them into CD11c 
high, intermediate, and low fractions. The CD11c-high DCs, 
which are also MHC II high, were the main active cells,   
whereas CD11c-intermediate cells that include macrophages 
and plasmacytoid DCs had much lower activity, and CD11c-
low lymphocytes were almost inactive (Fig. S1 A).
To test if the Foxp3+ iT reg cells exhibited suppressive 
activity, 5-d MLR cultures were sorted into dominant RFP+ 
and  minor  CD4+CD25Foxp3  fractions  that  were  then 
added in graded doses to a fresh MLR between BALB/c DCs 
and CD45.1+ CFSE-labeled CD4+ naive B6 T cells. At ratios 
of 1:3 to 1:27 iT reg cells/fresh T cells, iT reg cells (Fig. 1 C, 
blue triangles; and Fig. S1 B), but not Foxp3 cells (pink 
squares), significantly suppressed the MLR. The suppression 
by iT reg cells was equivalent to nT reg cells generated in the 
presence of IL-2 as described previously (Yamazaki et al., 2006; 
In this paper, we will show that induced Foxp3+ T reg 
cells can have many features of an adaptive immune response. 
We find that mouse spleen DCs are specialized inducers of 
antigen-specific and suppressive iT reg cells from the alloreac-
tive T cell repertoire, in the presence of exogenous TGF- 
and ATRA. Although prior studies either failed to restimulate 
iT reg cells (Floess et al., 2007) or required exogenous addi-
tion of the suppressive cytokine TGF- (Polansky et al., 2008; 
Koenecke et al., 2009), a cytokine which might not be avail-
able under inflammatory condition in vivo, we observe that 
iT reg cells can be restimulated specifically by DCs in vitro in 
the absence of TGF-. Importantly, the DC-induced Foxp3+ 
iT reg cells suppress graft versus host disease (GVHD), main-
taining foxp3 expression for 6 mo and acquiring a demethyl-
ated foxp3 CNS2 sequence comparable to nT reg cells.
RESULTS
DCs induce antigen-specific suppressive iT reg cells  
from a polyclonal T cell repertoire in the presence  
of added TGF- and ATRA
To induce iT reg cells from the polyclonal repertoire, we 
tested splenic BALB/c DCs as stimulators of C57BL/6 T cells 
in a mixed leukocyte reaction (MLR) together with TGF-, 
a known co-factor for iT reg cell development, according to 
Chen et al. (2003). To deplete the starting B6 CD4+ respond-
ing T cells of preexisting T reg cells, we always used B6.FIR 
mice in which the Foxp3 promoter drives RFP expression 
(Wan and Flavell, 2005). CD4+CD25Foxp3 (RFP) cells 
were isolated by FACS sorting and stimulated with DCs plus 
Figure 1.  DCs induce suppressive 
CD4+CD25+Foxp3+ (RFP+) cells from a polyclonal 
T cell repertoire. (A) Sorted C57BL/6 
CD4+CD25Foxp3 (RFP) cells were cultured 5 d 
with BALB/c splenic CD11c+ DCs alone (MLR), or with 
20 ng/ml TGF- with or without graded doses of 
ATRA. Typical FACS plots (top) and data on the fre-
quency (bottom, blue) and absolute number (bottom, 
red) of CD4+CD25+Foxp3+ (RFP+) iT reg cells at day 5 
(mean ± SD). (B) As in A, but T reg cell induction 
(dashed and solid lines indicate frequency and abso-
lute number, respectively) in an MLR with CD11c+ 
DC-enriched (CD11c Pos) and CD11c DC-depleted 
(CD11c Neg) BALB/c spleen cells with 20 ng/ml 
TGF- and 10 nM ATRA. (C) iT reg cells, as well as 
CD25Foxp3 (RFP; non T reg) cells, were isolated 
from a day-5 MLR as in A. Cells were then added to a 
fresh 5-d MLR between CFSE-labeled C57BL/6 CD45.1 
CD4+ T cells and BALB/c DCs to detect suppressive 
capacity (reduced CFSE dilution). We also tested 
C57BL/6 Foxp3+ nT reg cells expanded in MLR with 
IL-2. (D) As in C, but the suppressive activity of sorted 
iT reg cells induced with 20 ng/ml TGF- alone or 
together with ATRA were compared. (E) iT reg cells 
generated as in A were added to cultures comprised 
of BALB/c DCs and either CFSE-labeled naive C57BL/6 CD45.1+ CD4+ T cells (1° MLR) or sorted activated allospecific CD4+CD25+ cells generated from 
CD4+CD25 cells in a 1° MLR (2° MLR). 5 d after addition of sorted iT reg cells, suppression of either 1 or 2° MLR was compared by calculating the per-
centage (% of MLR) of CFSE-diluted cells out of total proliferating cells in MLR (see Fig. S1 C) or percentage of CFSE-diluted cells. One representative ex-
periment of three is shown. Error bars denote mean ± SD. *, P < 0.05.JEM Vol. 208, No. 12 
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1° and 2° MLR whether we enumerated the Foxp3 re-
sponse as frequency (Fig. 1 E) or total numbers (Fig. S1 D). 
Therefore, DC-induced iT reg cells suppress secondary or 
activated T cells at least as well as a primary response.
Polyclonal CD4+CD25+Foxp3+ iT reg cells are specific  
for antigens on the inducing DC
To evaluate the antigenic specificity of suppression, we first in-
duced C57BL/6 CD45.2+CD4+CD25Foxp3 (RFP) cells 
to become iT reg cells with either BALB/c or SJL DCs. Then 
we purified the RFP+ iT reg cells (suppressors) to test sup-
pression of fresh C57BL/6 CD45.1+CD4+ cells in a primary 
MLR stimulated with either BALB/c or SJL DCs (stimula-
tors; Fig. S2). When iT reg cells had been induced by BALB/c   
DCs, they more efficiently suppressed an 
MLR stimulated by Balb DCs than iT reg 
cells induced by SJL DCs (Fig. 2 A and   
Fig. S2), whereas the reverse was observed 
with an MLR stimulated with SJL DCs   
(Fig. 2 B and Fig. S2). These “criss-cross” 
experiments showed that DC-induced poly-
clonal CD4+CD25+Foxp3+ iT reg cells spe-
cifically suppress MLR alloreactivity.
Fig. 1 C, green circles). iT reg cells generated with ATRA 
were two- to threefold more effective on a cell-dose basis, in-
dicating that ATRA improved iT reg cell induction both in 
quantitative (Fig. 1 A) and qualitative (Fig. 1 D) terms. Given 
these findings, we used T reg cells that were induced with 
both ATRA and TGF- in all of the subsequent experiments.
To find out if iT reg cells could suppress an MLR when 
the responding T cells had been preactivated, we isolated 
activated CD4+CD25+Foxp3 cells at day 3–4 of an MLR 
culture. When CFSE-labeled activated and naive C57BL/6 
T cells were each challenged with allogeneic BALB/c DCs, 
the proliferation of activated T cells in a 2° MLR was four   
to five times stronger than the 1° MLR (Fig. S1 D, left data 
points), as expected. Nevertheless, iT reg cells suppressed both 
Figure 2.  Polyclonal CD4+CD25+Foxp3+ iT reg cells are specific for antigens on the inducing DC. Sorted C57BL/6 CD4+CD25Foxp3 (RFP) cells were 
incubated with either BALB/c (green) or SJL (gray) splenic CD11c+ DCs with TGF- and ATRA. After 5 d, the iT reg cells (CD4+CD25+Foxp3+RFP+) were sorted and 
compared for suppression (as in Fig. 1 C) of an MLR (blue) stimulated with either BALB/c (A) or SJL (B) CD11c+ DCs. One representative experiment of four is 
shown. Error bars denote mean ± SD. *, P < 0.05 comparing suppression between the two iT reg cells sources; **, P < 0.05 comparing suppression to MLR.
Figure 3.  Splenic DCs specifically restimulate 
allo-iT reg cells expansion. (A) Sorted iT reg cells 
induced with either BALB/c or SJL CD11c+ DCs were 
CFSE labeled and stimulated in various ratios with 
either BALB/c (left) or SJL (right) CD11c+ DCs. (B) As 
in A, but the restimulation cultures contained either 
control or anti–TGF- mAb (left) or anti–IL-2 mAb 
(right). 3 d later, live proliferating (CFSE diluted) 
CD3+CD4+Foxp3+ (RFP+) cells were analyzed by FACS. 
(C) Proliferating iT reg cells numbers with or without 
restimulation with BALB/c DCs over 3 d. (D) As in C, 
but after 3 d of DC restimulation, the CFSE-diluted 
CD3+CD4+Foxp3+ (RFP+) iT reg cells and CD3+CD4+ 
Foxp3 (RFP) ex-Foxp3 cells were sorted and  
incubated for 2 d, and IL-2 in the medium was  
measured by ELISA. One representative experiment  
of three is shown. Error bars denote mean ± SD.2492 DCs induce stable antigen-specific T reg cells for adoptive transfer | Sela et al.
totally dependent on IL-2 (Fig. 3 B, right). 
Kinetic studies showed that restimulated 
iT reg cells were already expanding at 
day 2 of the secondary cultures (Fig. 3 C, 
left). Approximately 25–35% of the restim-
ulated iT reg cells lost Foxp3 on day 2–3 
(Fig. 3 C bottom right; and Fig. S3 B), 
whereas in the absence of DCs, iT reg 
cells did not proliferate (Fig. 3 C top 
right) and only 5% lost Foxp3 (Fig. S3 B). When we sorted 
Foxp3+ and Foxp3 cells from the restimulation cultures, only 
Foxp3 or “ex- Foxp3” were producing IL-2 (Fig. 3 D). Also, 
the sorted restimulated IL-2–dependent daughter Foxp3+ cells 
were functional and able to suppress fresh T cell proliferation 
(Fig. S3 C). These data indicate that polyclonal iT reg cells in-
duced by DCs are able to be restimulated upon contact with 
specific antigen and IL-2, and that most continue to express 
Foxp3. Given these properties, we decided to proceed with 
in vivo experiments to determine if iT reg cells could persist 
under inflammatory conditions.
iT reg cells induced by DCs suppress GVHD.
To study the persistence and function of allospecific iT reg 
cells in vivo, we created a GVHD model based on prior   
work (Taylor et al., 2002). We transferred 106 C57BL/6 
CD4+CD45RBhiCD25CD45.1+  cells  into  4–5-wk  non-
irradiated BALB/c scid (C.B-17) mice lacking lymphocytes. 
GVHD gradually developed over 1.5–2 mo with weight loss, 
diarrhea, and skin lesions, including alopecia and eruptions, 
starting around the eyes and nose and extending to the back 
(Fig. S4 and Table I). Splenomegaly and lymphadenopathy 
developed (Fig. S4), as well as systemic multiorgan inflamma-
tion mainly in the bowel, liver, skin, and lung, whereas the 
disease-inducing C57BL/6 CD4+CD45RBhi cells infiltrated 
these sites (not depicted). The mice lost weight progressively 
and survived 2 mo on average (Fig. 4 A, right). Life spans 
were shorter if more CD4+CD45RBhi cells were injected 
(not depicted). When we simultaneously transferred C57BL/6 
anti-BALB/c CD45.2+ iT reg cells, GVHD was markedly 
attenuated, and the recipients of iT reg cells were almost free 
of disease manifestations (Fig. 4 A, right; and Table I), for ex-
ample, weight loss, skin involvement, and diarrhea, at a time 
when  most  PBS-treated  mice  had  died.  To  evaluate  the 
Splenic DCs specifically restimulate allo-iT reg cells  
but independently of TGF-
To determine if iT reg cells could undergo restimulation, and 
to further assess their specificity, we set up secondary DC re-
stimulation cultures. Successful restimulation would also in-
dicate that iT reg cells had a measure of stability, which to 
our knowledge has not been established for antigen-specific 
iT reg cells from the polyclonal repertoire. When B6 iT reg 
cells were induced by BALB/c DCs, they were restimulated 
more vigorously by BALB/c than SJL DCs (Fig. 3 A, left, 
blue vs. pink), whereas iT reg cells induced by SJL DCs re-
sponded better to SJL versus BALB/c (Fig. 3 A, right, pink 
vs. blue). In the suppression cultures, simultaneously with 
suppression of T cell proliferation, the iT reg cells prolifer-
ated achieving a high ratio of CFSE-diluted iT reg cells to 
suppressed CFSE-diluted T cells (Fig. S3 A).
To begin to understand mechanisms for restimulation by 
DCs, we used blocking mAbs. Surprisingly restimulation of 
iT reg cells no longer required TGF- (Fig. 3 B, left) but was 
Table I.  Clinical manifestations
Induction + Prevention Alopecia 
2 mo
Alopecia 
6 mo
Diarrhea 
2 mo
Diarrhea 
6 mo
PBS + PBS A A No No
CD4 + CD45RBhigh  
+ PBS
C — Yes —
CD4 + CD45RBhigh  
+ iT reg cells
A B–C No No
C.B-17 scid (BALB/c) mice were transferred with allogeneic C57BL/6 
CD4+CD45RBhiCD25CD45.1+ cells (induction) along with PBS or anti-Balb iT reg cells 
(prevention). Control mice were injected twice with PBS (PBS + PBS). Skin manifestations 
and diarrhea were evaluated 2 and 6 mo later. Grading of skin involvement: A, no 
involvement; B, involvement of mouth or nose; C, involvement of back. Diarrhea was 
graded as yes or no. — denotes that this mouse group did not survive.
Figure 4.  iT reg cells induced by DCs sup-
press GVHD. (A) C.B-17 scid (BALB/c) mice 
were transferred with allogeneic C57BL/6 
CD4+CD45RBhiCD25 CD45.1 (disease inducing) 
cells along with PBS or anti-Balb iT reg cells. In 
parallel, control mice were injected twice with 
PBS (PBS+PBS). Animal survival (left) and weight 
(right) were followed. (B) H&E inflammation 
score of tissues 2–2.5 mo after disease induction 
with CD4+ CD45.1 T cells, with or without pre-
vention with CD4+ CD45.2 Foxp3+(RFP+) cells. 
One representative experiment of three is 
shown. Error bars denote mean ± SD.JEM Vol. 208, No. 12 
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eliminate disease-inducing cells but rather 
suppressed them. When we followed the 
mice for longer periods, iT reg cells were 
found in lymphoid and other organs 6 mo 
after adoptive transfer (Fig. 5 A), although 
the  mice  were  starting  to  have  signs  of 
GVHD (Table I and Fig. S4 D).
Because previous studies attributed ther-
apeutic failures with iT reg cells to Foxp3 
gene instability (Edinger, 2009), we studied 
CpG methylation status in CNS2 (Fig. 5 B), 
a region of the Foxp3 gene linked to main-
tenance and stability of this transcription 
factor (Zheng et al., 2010). Immediately after induction, iT reg   
cells had almost fully methylated CpG in CNS2 (Fig. 5 B) 
compared with demethylation in nT reg cells. However, 
CNS2 demethylation in iT reg cells increased significantly 3 d 
after restimulation in vitro but, more strikingly, 1.5 mo after 
transfer  of  the  iT  reg  cells  in  vivo,  when  demethylation 
matched nT reg cells (Fig. 5 B). Thus iT reg cells stability and 
Foxp3 CNS2 demethylation are both associated with pro-
longed iT reg cells survival and GVHD remission in vivo.
iT reg cells induced by DCs can treat active GVHD
To verify that iT reg cells can persist and function when 
adoptively transferred under ongoing conditions of inflam-
mation and active GVHD, we conducted a treatment experi-
ment. The mice were treated with iT reg cells at 2 wk, after 
the onset of weight loss (Fig. 5 C) and up-regulation in IFN- 
(not depicted), and compared with control and prevention 
groups (iT reg cell treatment at time 0). After treatment with 
iT reg cells, the mice were monitored for an additional 7 wk. 
The iT reg cell–treated sick mice regained weight to an al-
most equivalent level to that of healthy control mice and 
length of the remission brought about with iT reg cells, we 
followed  the  mice  for  6  mo.  In  three  experiments,  mice 
treated with iT reg cells survived for 6 mo after disease in-
duction (Fig. 4 A), whereas none of the mice induced with 
CD4+CD45RBhi cells and treated with PBS survived 2.5 mo. 
This was associated with a significantly better H&E inflam-
mation score of several organs (Fig. 4 B). Thus, DC-induced 
antigen-specific iT reg cells can prevent GVHD, extending 
prior evidence that adoptively transferred nT reg cells also 
can prevent GVHD (Joffre et al., 2008).
Alloreactive DC-induced T reg cells remain stable  
for months in vivo and acquire highly demethylated  
foxp3 CNS2 gene sequences
To determine if the transferred iT reg cells persisted in these 
recipients, we looked for CD45.2+ cells 2.5 mo after adoptive 
transfer. Many CD45.2+CD4+Foxp3+ cells were observed in 
all organs tested, including lymphoid tissues (Fig. S5 A), liver, 
and lung (not depicted). Although these mice were clinically 
healthy, we could find disease-inducing CD45.1+ cells in 
all these sites (Fig. S5), suggesting that iT reg cells did not 
Figure 5.  iT reg cells induced by DCs persist 
in vivo and remain stable. (A) C.B-17 scid (BALB/c) 
mice were transferred with allogeneic (C57BL/6) 
CD4+CD45RBhiCD25 CD45.1 disease-inducing cells 
along with either PBS or with anti-Balb iT reg cells. 
Infiltration of secondary lymphoid organs and tis-
sues with CD4+ CD45.1 disease-inducing cells and 
CD4+CD45.2 Foxp3+ (RFP+) disease protective cells 
was analyzed by FACS 6 mo after GVHD induction. 
(B) iT reg cells from a primary MLR (iT reg cells) or 
restimulated (3 d) with allo DC (restimulated iT reg 
cells), or iT reg cells 1.5 mo after adoptive transfer 
(in vivo iT reg cells), were compared with naive CD4+ 
cells or nT reg cells for CpG dinucleotide methylation 
at CNS2 of the Foxp3 gene by Bisulfite pyrosequenc-
ing. (C) As in Fig. 4 A, but with an additional group of 
mice that were injected with iT reg cells as treatment 
only after the appearance of weight loss at 2 wk. 
(D) Infiltration of secondary lymphoid organs and 
tissues with CD4+ CD45.1 and CD4+ CD45.2 Foxp3+ 
(RFP+) of sick mice that were treated with iT reg cells. 
One representative experiment of three is shown. 
Error bars denote mean ± SD. *, P < 0.05.2494 DCs induce stable antigen-specific T reg cells for adoptive transfer | Sela et al.
DCs alone can restimulate iT reg cells that maintain a high 
rate of Foxp3 expression without the need for exogenous 
cytokine supplementation. Perhaps our results reflect the 
very high frequency of iT reg cells in our primary MLR cul-
tures. Nevertheless, not all Foxp3+ iT reg cells induced in a 
primary MLR were stable. A minority lost Foxp3 expression 
when rechallenged with DCs, and began to make IL-2 (most 
of the ex-Foxp3 cells were described to be methylated; Zhou 
et al., 2009). The population of iT reg cells that maintained 
Foxp3 exhibited higher levels of CNS2 demethylation in   
the Foxp3 gene, a marker for stability. IL-2 is known to 
maintain Foxp3+ nT reg cells in vivo (Oldenhove et al., 2009; 
Grinberg-Bleyer et al., 2010), and we found that IL-2 gener-
ated by ex-Foxp3 cells, but not TGF-, was required for 
DCs to restimulate iT reg cells. Several recent publications 
(Wan and Flavell, 2005, 2007; Tang et al., 2008; Yang et al., 
2008; Murai et al., 2009; Zhou et al., 2009) have reported 
that T reg cells in the context of inflammation lower Foxp3 
expression. In contrast, the DC-induced iT reg cells we stud-
ied were specifically suppressive and a significant fraction was 
able to persist and function in vivo and under inflammatory 
conditions. This encourages the use of DCs to generate antigen-
specific iT reg cells for therapeutic use.
MATERIALS AND METHODS
Mice. We purchased 6–8-wk-old female BALB/c H-2d, C57BL/6 CD45.1 
H-2b, and SJL H-2s mice from Taconic and 3–4-wk-old C.B-17 scid (BALB/
c background) mice from The Jackson Laboratory. Foxp3-IRES-RFP (FIR) 
knock-in mice were a gift from R. Flavell (Yale University, New Haven, 
CT; Wan and Flavell, 2005). We followed guidelines of the institutional ani-
mal care and use committee of the Rockefeller University.
Antibodies and reagents. We purchased from BD APC conjugated anti–
mouse CD25, -CD4, -CD45.1, and -CD11c; Alexa Fluor 700–conjugated 
anti-CD3, -CD4, and -CD11c; PE-conjugated anti-CD3, -CD19, and   
-CD49b; FITC-conjugated anti-CD3, -CD19, -CD49b, and isotype con-
trol; biotin anti-CD4, -CD8, -DX5, -B220, -CD3, -CD11b, -Ly-6G, and   
-Ter119; and purified anti-CD16/CD32 (2.4G2). We purchased CD11c 
and streptavidin beads (SA) from Miltenyi Biotec; CFSE and live dead fix-
able aqua from Invitrogen; ATRA from Sigma-Aldrich; human TGF-1, 
anti–mouse TGF- (1D11), anti–IL-2, and Ig isotype control from R&D 
Systems; and IL-2 from Novartis or PeproTech.
T cells and DCs. Non-CD4+ lymph node and spleen T cells were re-
moved by MACS beads (Miltenyi Biotec) after coating with biotin anti-
CD8, DX5, B220, CD3, CD11b, Ly-6G, and Ter119 and were further 
purified with a FACSAria 2 sorter (BD) to >97%. Spleen CD11c+ DCs were 
partially enriched with anti-CD11c beads (Miltenyi Biotec) and, where in-
dicated, purified with a FACSAria 2 or FACSVantage (BD) cell sorter as 
CD11chighCD19CD3DX5 DCs (>95%).
De novo in vitro induction of T reg cells in the allo-MLR. CD4+ 
T cells from C57BL/6 Foxp3 RFP mice were sorted as CD4+CD25RFP 
cells. These T cells were then co-cultured for 5 d with fresh splenic BALB/c 
DCs. Induction of CD4+CD25+RFP+ cells was analyzed by FACS (LSR-II; 
BD) and FlowJo software (Tree Star) and sorted (FACSAria 2) as needed for 
functional assays.
In  vitro  suppression  assay.  iT  reg  cells  or  activated  nT  reg  cells 
(CD4+CD25+RFP+ from naive mice activated for 5 d with allo-DCs) 
were  co-cultured  in  round-bottom  96-well  plates  with  CFSE-labeled  fresh 
equivalent to mice that were given iT reg cells as prevention. 
This is in contrast to untreated mice that continued to lose 
weight (Fig. 5 C), developed skin manifestation and diarrhea, 
and died early (not depicted). This significant improvement 
with treatment was accompanied by the persistence of iT reg 
cells in secondary lymphoid tissues and organs 7 wk after   
iT reg cell adoptive transfer to sick mice (Fig. 5 D).
DISCUSSION
We have chosen the MLR to generate antigen-specific iT reg 
cells from a polyclonal repertoire because many T cells are 
allospecific (Steinman and Witmer, 1978), and there are excel-
lent models of GVHD to study the in vivo function of the 
iT reg cells. It is known that DCs induce Foxp3+ T reg cells 
through endogenous (Coombes et al., 2007; Sun et al., 2007; 
Yamazaki et al., 2007) or exogenous (Luo et al., 2007) TGF-, 
using stimulation of bulk populations with anti-CD3 or TCR 
transgenic T cells with antigen. In this study, we used BALB/c 
DCs to present antigens to polyclonal allogeneic C57BL/6 
Foxp3CD4+ T cells in the presence of TGF- and ATRA 
(although the iT reg cells were also induced when the MLR 
was run in the reverse direction; unpublished data). We found 
that the DCs induced iT reg cells efficiently because most of 
the MLR proliferating cells became Foxp3+ at a DC/T cell 
ratio of 1:10. These iT reg cells specifically suppressed alloim-
munity in vitro, both by naive and previously activated T cells 
(primary and secondary MLR). Importantly, the iT reg cells 
also suppressed active GVHD and persisted in vivo under con-
ditions of inflammation, although in vivo conversion to ex-
Foxp3 cells was observed (25–30%; Fig. S5 B).
The development of clinical manifestations of GVHD   
after 6 mo suggests that treatment with iT reg cells in our ex-
periments does not bring to cure, as although they persisted, 
the iT reg cells did not eliminate the disease-inducing cells 
(2.5 and 6 mo after adoptive transfer) but rather induced pro-
longed remission. If treatment with iT reg cells will come to 
patients in the future, this may suggest that at this point when 
there is relapse in clinical manifestations, a boost with iT reg 
cells might be given to renew the remission. In addition, re-
garding the possibility that iT reg cells converted to ex-Foxp3 
will mediate development of GVHD, we injected iT reg cells 
alone and monitored the mice for 2 mo. During this time, we 
did not observe any clinical change comparing to healthy 
mice (unpublished data).
The latter findings were surprising because prior publica-
tions questioned the stability of Foxp3+ expression by in vitro 
generated iT reg cells (Floess et al., 2007). Because of this in-
stability, the therapeutic use of iT reg cells was questioned 
(Sakaguchi et al., 2008; Edinger, 2009). However, iT reg 
cells were not previously shown to undergo restimulation 
in vitro with DCs from lymphoid tissues, which are known to 
induce T  reg  cells  from  antigen-specific TCR  transgenic   
T cells (Kretschmer et al., 2005; Luo et al., 2007; Yamazaki 
et al., 2007).
We found, in contrast to previous publication (Floess et al., 
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CD45.1+CD4+ T cells at the indicated ratios plus allo-DCs (ratio of 1 DC to 3 
CD45.1+ CD4+ T cells). After 5 d, proliferation was assessed by FACS 
(LSR-II; BD) to determine CFSE diluted, live CD45.1+ T cells. Statistical 
data (Student’s t test) were analyzed using Excel (Microsoft).
Restimulation of iT reg cells. Sorted DC-induced T reg cells were la-
beled with CFSE and recultured with fresh allo-DCs for several days as indi-
cated, after which CFSE dilution as a marker for iT reg cells proliferation 
was analyzed by FACS (LSR-II).
GVHD induction, prevention, and treatment. To induce GVHD, 106 
sorted (FACSAria 2) CD45.1+CD4+CD45RbhiCD25 cells were injected i.v. 
into 4–5-wk-old C.B-17 scid (BALB/c background) mice. For prevention, the 
mice were concomitantly injected with BALB/c DC-induced T reg cells in 
five separate injections (0.8 × 106 every 3 d over 12 d) to a total of 4 × 106 cells 
per mouse. The mice were monitored weekly for skin manifestations, diar-
rhea, weight, and survival. Tissues were stained with H&E to evaluate pathol-
ogy and scoring was done as previously described (Blazar et al., 1998). CD3+ 
T cells in different tissues were analyzed for CD45.1 disease-inducing T cells 
and CD45.2 disease-suppressing iT reg cells by FACS. For treatment, after in-
jection of CD45.1+CD4+CD45RbhiCD25 cells, the mice were monitored 
for weight loss and up-regulation of IFN- and then treatment with iT reg 
cells was started. Statistical data were analyzed with Prism (GraphPad Software) 
for nonparametric Mann-Whitney U test and for survival.
Methylation analysis. CpG dinucleotide methylation analysis of the Foxp3 
CNS2 (Zheng et al., 2010) sequence was determined by bisulfite treatment 
of RNase-treated genomic DNA, followed by PCR amplification and pyro-
sequencing. Pyro Q–CpG was performed by EpigenDX.
Online  supplemental  material.  Fig.  S1  shows  that  DCs  generate   
de novo suppressive CD4+CD25+Foxp3+ (RFP+) from a polyclonal T cell 
repertoire in the MLR. Fig. S2 shows that polyclonal CD4+CD25+Foxp3+ 
iT reg cells are specific for antigens on the inducing DC. Fig. S3 shows 
that splenic DCs efficiently restimulate allo–iT reg cells that maintain their 
suppressive activity. Fig. S4 shows that iT reg cells induced by DCs sup-
press GVHD in vivo. Fig. S5 shows that iT reg cells induced by DCs per-
sist in vivo. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20110466/DC1.
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